LiPlasome Pharma

About:

LiPlasome, a biotech company focused on oncology, provides a liplasomal reformulation of anticancer drugs on the market.

Website: http://www.liplasome.com

Top Investors: Incuba Venture, Vecata, BankInvest Biomedical Venture

Description:

LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin -> LiPlaCis®, Oxaliplatin -> LiPloxa. The aim is to provide more effective treatment to cancer patients with fewer side effects.